Idera Pharmaceuticals, Inc.
IDRA · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $1,140 | $1,772 | $7,300 | $3,056 |
| - Cash | $12,044 | $32,545 | $33,229 | $40,019 |
| + Debt | $560 | $758 | $949 | $1,062 |
| Enterprise Value | -$10,344 | -$30,015 | -$24,980 | -$35,901 |
| Revenue | $0 | $0 | $0 | $1,448 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | $1,448 |
| % Margin | – | – | – | 100% |
| EBITDA | -$27,818 | $98,120 | -$112,598 | -$56,395 |
| % Margin | – | – | – | -3,894.7% |
| Net Income | -$23,360 | $98,084 | -$112,662 | -$84,558 |
| % Margin | – | – | – | -5,839.6% |
| EPS Diluted | -7.18 | 31.55 | -56.63 | -33.66 |
| % Growth | -122.8% | 155.7% | -68.2% | – |
| Operating Cash Flow | -$24,495 | -$24,597 | -$33,772 | -$44,498 |
| Capital Expenditures | $0 | $0 | -$8 | -$11 |
| Free Cash Flow | -$24,495 | -$24,597 | -$33,780 | -$44,509 |